The DOI matches its Crossref record; 40 of the 41 references it cites were found in a registry or an index.
Signatures of mutation and selection in the cancer genome
Open accessAbstract
The cancer genome is moulded by the dual processes of somatic mutation and selection. Homozygous deletions in cancer genomes occur over recessive cancer genes, where they can confer selective growth advantage, and over fragile sites, where they are thought to reflect an increased local rate of DNA breakage. However, most homozygous deletions in cancer genomes are unexplained. Here we identified 2,428 somatic homozygous deletions in 746 cancer cell lines. These overlie 11% of protein-coding genes that, therefore, are not mandatory for survival of human cells. We derived structural signatures that distinguish between homozygous deletions over recessive cancer genes and fragile sites. Application to clusters of unexplained homozygous deletions suggests that many are in regions of inherent fragility, whereas a small subset overlies recessive cancer genes. The results illustrate how structural signatures can be used to distinguish between the influences of mutation and selection in cancer genomes. The extensive copy number, genotyping, sequence and expression data available for this large series of publicly available cancer cell lines renders them informative reagents for future studies of cancer biology and drug discovery. Two Articles in this issue add major data sets to the growing picture of the cancer genome. Bignell et al. analysed a large number of homozygous gene deletions in a collection of 746 publicly available cancer cell lines. Combined with information about hemizygous deletions of the same genes, the data suggest that many deletions found in cancer reflect the position of a gene at a fragile site in the genome, rather than as a recessive cancer gene whose loss confers a selective growth advantage. Beroukhim et al. present the largest data set to date on somatic copy-number variations across more than 3,000 specimens of human primary cancers. Many alterations are shared between multiple tumour types. Functional experiments demonstrate an oncogenic role for the apoptosis genes MCL1 and BCL2L1 that are associated with amplifications found in many cancers. Homozygous gene deletions in cancer cells occur over recessive cancer genes (where they can confer selective growth advantage) or over genes at fragile sites of the genome (where they are thought to reflect increased DNA breakage). Here, a large number of homozygous deletions in a collection of cancer cell lines are identified and analysed to derive structural signatures for the two different types of deletion. More deletions are found in inherently fragile regions, and fewer overlying recessive genes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“tandem repeat-containing regions we identified co-localized to 9 of 11 (81.8%) of the molecularly mapped rare folate-sensitive fragile sites37, all at CG-containing tandem repeats”
From Genome-wide detection of tandem DNA repeats that are expanded in autism (2020) · cites this paper as [37]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function
Melo, S. A., Ropero, S., Moutinho, C., Aaltonen, L. A., Yamamoto, H., Calin, G. A., Rossi, S., Fernández, A. F., Carneiro, F., Oliveíra, C., et al. (2009) · Nature Genetics · doi:10.1038/ng.317 · Cited by 375
RetractedControlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., et al. (1997) · Science · doi:10.1126/science.275.5308.1943 · Cited by 4,785
Stratton, M. R., Campbell, P. J., & Futreal, P. A. (2009) · Nature · doi:10.1038/nature07943 · Cited by 3,625
Self-citationThe Consensus Coding Sequences of Human Breast and Colorectal Cancers
Sjöblom, T., Jones, S., Wood, L. D., Parsons, D. W., Lin, J., Barber, T. D., Mandelker, D. L., Leary, R. J., Ptak, J., Silliman, N., et al. (2006) · Science · doi:10.1126/science.1133427 · Cited by 3,161
Somatic mutations affect key pathways in lung adenocarcinoma
Ding, L., Getz, G., Wheeler, D. A., Mardis, E. R., McLellan, M. D., Cibulskis, K., Sougnez, C., Greulich, H., Muzny, D. M., Morgan, M. B., et al. (2008) · Nature · doi:10.1038/nature07423 · Cited by 2,681
Inactivation of the Type II TGF-β Receptor in Colon Cancer Cells with Microsatellite Instability
Markowitz, S. D., Wang, J., Myeroff, L. L., Parsons, R. E., Sun, L., Lutterbaugh, J., Fan, R. S., Zborowska, E., Kinzler, K. W., Vogelstein, B., et al. (1995) · Science · doi:10.1126/science.7761852 · Cited by 2,267
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions
Gorgoulis, V. G., Vassiliou, L.-V. F., Karakaidos, P., Zacharatos, P., Kotsinas, A., Liloglou, T., Venere, M., DiTullio, R. A., Kastrinakis, N. G., Levy, B., et al. (2005) · Nature · doi:10.1038/nature03485 · Cited by 2,009
Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer
Versteege, I., Sévenet, N., Lange, J., Rousseau-Merck, M.-F., Ambros, P. F., Handgretinger, R., Aurias, A., & Delattre, O. (1998) · Nature · doi:10.1038/28212 · Cited by 1,552
Ozawa, M., Baribault, H., & Kemler, R. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03563.x · Cited by 1,396
Rampino, N. J., Yamamoto, H., Ionov, Y., Li, Y., Sawai, H., Reed, J. C., & Perucho, M. (1997) · Science · doi:10.1126/science.275.5302.967 · Cited by 1,326
Characterizing the cancer genome in lung adenocarcinoma
Weir, B. A., Woo, M. S., Getz, G., Perner, S., Ding, L., Beroukhim, R., Lin, W. M., Province, M. A., Kraja, A., Johnson, L. A., et al. (2007) · Nature · doi:10.1038/nature06358 · Cited by 1,105
Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas
Pasqualucci, L., Neumeister, P., Goossens, T., Nanjangud, G., Chaganti, R. S. K., Küppers, R., & Dalla-Favera, R. (2001) · Nature · doi:10.1038/35085588 · Cited by 1,032
Integrated detection and population-genetic analysis of SNPs and copy number variation
McCarroll, S. A., Kuruvilla, F. G., Korn, J. M., Cawley, S., Nemesh, J., Wysoker, A., Shapero, M. H., de Bakker, P. I. W., Maller, J. B., Kirby, A., et al. (2008) · Nature Genetics · doi:10.1038/ng.238 · Cited by 936
Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus
Kamb, A., Shattuck-Eidens, D. M., Eeles, R. A., Liu, Q., Gruis, N. A., Ding, W., Hussey, C. E., Tran, T., Miki, Y., Weaver-Feldhaus, J., et al. (1994) · Nature Genetics · doi:10.1038/ng0994-22 · Cited by 855
Structural Evidence for the Authenticity of the Human Retinoblastoma Gene
Fung, Y.-K. T., Murphree, A. L., Tang, A., Qian, J., Hinrichs, S. H., & Benedict, W. F. (1987) · Science · doi:10.1126/science.2885916 · Cited by 780
Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers
Thiagalingam, S., Christoph Lengauer, C., Leach, F. S., Schutte, M. E. M., Hahn, S. A., Overhauser, J., Willson, J. K. V., Markowitz, S. D., Hamilton, S. R., Kern, S. E., et al. (1996) · Nature Genetics · doi:10.1038/ng0796-343 · Cited by 616
Two levels of protection for the B cell genome during somatic hypermutation
Liu, M., Duke, J. L., Richter, D. J., Vinuesa, C. G., Goodnow, C. C., Kleinstein, S. H., & Schatz, D. G. (2008) · Nature · doi:10.1038/nature06547 · Cited by 574
ATR Regulates Fragile Site Stability
Casper, A. M., Nghiem, P., Arlt, M. F., & Glover, T. W. (2002) · Cell · doi:10.1016/s0092-8674(02)01113-3 · Cited by 572
Ried, K. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.11.1651 · Cited by 274
p15Ink4b is a critical tumour suppressor in the absence of p16Ink4a
Krimpenfort, P., IJpenberg, A., Song, J.-Y., van der Valk, M., Nawijn, M., Zevenhoven, J., & Berns, A. (2007) · Nature · doi:10.1038/nature06084 · Cited by 269
Copy number variation and evolution in humans and chimpanzeesPreprint
Perry, G. H., Yang, F., Marquès‐Bonet, T., Murphy, C., Fitzgerald, T. W., Lee, A. S., Hyland, C., Stone, A. C., Hurles, M. E., Tyler‐Smith, C., et al. (2008) · Genome Research · doi:10.1101/gr.082016.108 · Cited by 223
Self-citationLiu, T. X., Becker, M. W., Jelı́nek, J., Wu, W.-S., Deng, M., Mikhalkevich, N., Hsu, K., Bloomfield, C. D., Stone, R. M., DeAngelo, D. J., et al. (2006) · Nature Medicine · doi:10.1038/nm1512 · Cited by 209
Lukusa-Tshilobo, P., & Fryns, J. P. (2007) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2007.10.005 · Cited by 207
Human mitogen-activated protein kinase kinase 4 as a candidate tumor suppressor.
Teng, D. H. ‐., Perry, W. L., Hogan, J. K., Baumgard, M. L., Bell, R. N., Berry, S., Davis, T., Frank, D., Frye, C., Hattier, T., et al. (1997) · PubMed · Cited by 193
PICNIC: an algorithm to predict absolute allelic copy number variation with microarray cancer data
Greenman, C., Bignell, G. R., Butler, A. P., Edkins, S., Hinton, J., Beare, D. M., Swamy, S., Santarius, T., Chen, L., Widaa, S., et al. (2009) · Biostatistics · doi:10.1093/biostatistics/kxp045 · Cited by 193
Self-citationArlt, M. F., Mullé, J. G., Schaibley, V. M., Ragland, R. L., Durkin, S. G., Warren, S. T., & Glover, T. W. (2009) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2009.01.024 · Cited by 147
Bader, S. A., Walker, M., Hendrich, B., Bird, A. P., Bird, C. C., Hooper, M., & Wyllie, A. H. (1999) · Oncogene · doi:10.1038/sj.onc.1203229 · Cited by 137
Schwartz, M., Zlotorynski, E., Goldberg, M., Ozeri, E., Rahat, A., le Sage, C., Chen, B. P. C., Chen, D. J., Agami, R., & Kerem, B. (2005) · Genes & Development · doi:10.1101/gad.340905 · Cited by 134
Mutational Inactivation of PTPRD in Glioblastoma Multiforme and Malignant Melanoma
Solomon, D. A., Kim, J.-S., Cronin, J. C., Sibenaller, Z. A., Ryken, T. C., Rosenberg, S. A., Ressom, H. W., Jean, W. C., Bigner, D. D., Yan, H., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-3272 · Cited by 126
Feedback Circuit among INK4 Tumor Suppressors Constrains Human Glioblastoma Development
Wiedemeyer, R., Brennan, C., Heffernan, T. P., Xiao, Y., Mahoney, J. E., Protopopov, A. I., Zheng, H., Bignell, G. R., Furnari, F. B., Cavenee, W. K., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.02.010 · Cited by 118
Self-citationBullions, L. C., Notterman, D. A., Chung, L. S., & Levine, A. J. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.8.4501 · Cited by 108
Roles of FHIT and WWOX fragile genes in cancer
Iliopoulos, D., Güler, G., Han, S., Druck, T., Ottey, M., McCorkell, K. A., & Huebner, K. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.06.048 · Cited by 86
The αE-catenin gene (CTNNA1) acts as an invasion-suppressor gene in human colon cancer cells
Vermeulen, S. J. T., Nollet, F., Teugels, E., Vennekens, K., Malfait, F., Philippé, J., Speleman, F., Bracke, M., Roy, F. M. V., & Mareel, M. M. K. (1999) · Oncogene · doi:10.1038/sj.onc.1202348 · Cited by 74
Definition of the zebrafish genome using flow cytometry and cytogenetic mapping
Freeman, J. L., Adeniyi, A., Banerjee, R., Dallaire, S., Maguire, S. F., Chi, J., Ng, B. L., Zepeda, C., Scott, C. E., Humphray, S., et al. (2007) · BMC Genomics · doi:10.1186/1471-2164-8-195 · Cited by 74
Self-citationChromosome fragility: molecular mechanisms and cellular consequences
Freudenreich, C. H. (2007) · Frontiers in bioscience · doi:10.2741/2437 · Cited by 58
Solomon, D. A., Kim, J.-S., Jean, W. C., & Waldman, T. A. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2084 · Cited by 45
Sample Type Bias in the Analysis of Cancer Genomes
Solomon, D. A., Kim, J.-S., Ressom, H. W., Sibenaller, Z. A., Ryken, T. C., Jean, W. C., Bigner, D. D., Yan, H., & Waldman, T. A. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1055 · Cited by 33
Novel aphidicolin‐inducible common fragile site FRA9G maps to 9p22.2, within the C9orf39 gene
Sawińska, M., Schmitt, J. G., Sagulenko, E., Westermann, F., Schwab, M., & Savelyeva, L. (2007) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20484 · Cited by 22
AutoCSA, an algorithm for high throughput DNA sequence variant detection in cancer genomes
Dicks, E., Teague, J. W., Stephens, P., Raine, K. M., Yates, A. D., Mattocks, C., Tarpey, P. S., Butler, A. P., Menzies, A. H., Richardson, D., et al. (2007) · Bioinformatics · doi:10.1093/bioinformatics/btm152 · Cited by 16
Self-citation
Flagged first, then by citations
1 of the 41 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
METABRIC Group, Curtis, C., Shah, S. P., Chin, S.-F., Turashvili, G., Rueda, O. M., Dunning, M. J., Speed, D., Lynch, A. G., Samarajiwa, S., et al. (2012) · Nature · doi:10.1038/nature10983 · Cited by 6,097
Mermel, C. H., Schumacher, S. E., Hill, B., Meyerson, M. M., Beroukhim, R., & Getz, G. A. (2011) · Genome biology · doi:10.1186/gb-2011-12-4-r41 · Cited by 3,520
Greaves, M., & Maley, C. C. (2012) · Nature · doi:10.1038/nature10762 · Cited by 3,162
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
Yachida, S., Jones, S., Bozic, I., Antal, T., Leary, R., Fu, B., Kamiyama, M., Hruban, R. H., Eshleman, J. R., Nowak, M. A., et al. (2010) · Nature · doi:10.1038/nature09515 · Cited by 2,502
Self-citationMassive genomic rearrangement acquired in a single catastrophic event during cancer development
Stephens, P. J., Greenman, C. D., Fu, B., Yang, F., Bignell, G. R., Mudie, L. J., Pleasance, E. D., Lau, K. W., Beare, D., Stebbings, L. A., et al. (2011) · Cell · doi:10.1016/j.cell.2010.11.055 · Cited by 2,414
Self-citation
Metadata
- Authors
- Bignell, G. R., Greenman, C. D., Davies, H., Butler, A. P., Edkins, S., Andrews, J. M., Buck, G., Chen, L., Beare, D., Latimer, C., Widaa, S., Hinton, J., Fahey, C., Fu, B., Swamy, S., Dalgliesh, G. L., Teh, B. T., Deloukas, P., Yang, F., Campbell, P. J., Futreal, P. A., & Stratton, M. R.
- Affiliations
- Wellcome Sanger Institute (GB)
- Van Andel Institute (US)
- Institute of Cancer Research (GB)
- Corresponding author
- Futreal, P. Andrew
- Stratton, Michael R.
- ORCID
- Venue
- Nature
- Published
- 2010-02
- Volume
- 463
- Issue
- 7283
- Pages
- 893-898
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3145113
- OpenAlex
- W2071734901
- Cited by
- 707
- References
- 41
- Citations by year
- 2026: 7 · 2025: 24 · 2024: 21 · 2023: 29 · 2022: 25 · 2021: 32 · 2020: 40 · 2019: 30 · 2018: 44 · 2017: 44 · 2016: 47 · 2015: 48 · 2014: 61 · 2013: 71 · 2012: 76
- FWCI
- 25.43
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Nature (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- UEA Digital Repository (University of East Anglia) (submittedVersion)
- Funders
- Wellcome Trust (077012/Z/05/Z, 088340, 093867)
- National Cancer Institute (P01CA155258)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- fragile sites, copy number variation, cancer cell lines, structural signatures, DNA breakage, Mcl-1, Bcl-xL, gene amplification, tumor suppressor
- MeSH terms
- Chromosomes, Human, DNA Mutational Analysis, Genes, Recessive, Homozygote, Humans, Models, Genetic, Neoplasms, Selection, Genetic, Reproducibility of Results, Genome, Human, Gene Deletion, Gene Dosage, Physical Chromosome Mapping, Oligonucleotide Array Sequence Analysis, Chromosome Fragile Sites, Cell Line, Tumor, Genes, Neoplasm, DNA Copy Number Variations
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
